The U.S. Department of Justice (DOJ) filed a complaint against a pharmaceutical company, claiming it had manipulated reimbursements for its eye care drug, thereby defrauding the country’s federal health insurance program and taxpayers of hundreds of millions of dollars.
Related Posts
Press Freedom Groups Condemn Killing of Journalists in Gaza Strike
Press freedom organizations say about 200 Palestinian reporters have been killed so far since the attacks on Gaza have… Read More
EXCLUSIVE: Azerbaijan Destroyed Armenian Drones With Belarusian Weapons, Leaked Report Says
The arms sales to Azerbaijan have heightened tension between Armenia and Belarus, which are supposed to be allies as part of… Read More